CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-22 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −45,967 | 354,033 | ||
| 2021-02-22 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −45,686 | 354,314 | ||
| 2021-02-22 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −45,895 | 54,105 | ||
| 2021-02-22 | Schaefer Eric Chief Accounting Officer | Sale | −3,842 | $39.20 | $151K | 88,474 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise | +35,000 | $6.98 | $244K | 91,767 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise | +25,000 | $5.79 | $145K | 116,767 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise | +25,000 | $8.98 | $225K | 141,767 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise | +25,000 | $3.81 | $95K | 166,767 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise | +25,485 | $2.90 | $74K | 192,252 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise | +50,394 | $2.63 | $133K | 242,646 |
| 2021-02-16 | ORDONEZ KATHY Director | Sale | −118,667 | $47.58 | $5.6M | 123,979 |
| 2021-02-16 | ORDONEZ KATHY Director | Sale | −101,004 | $48.47 | $4.9M | 22,975 |
| 2021-02-16 | ORDONEZ KATHY Director | Sale | −1,100 | $49.00 | $54K | 21,875 |
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise · Stock Option (right to buy) | −35,000 | 0 | ||
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise · Stock Option (right to buy) | −25,485 | 324,515 | ||
| 2021-02-16 | ORDONEZ KATHY Director | Option exercise · Stock Option (right to buy) | −50,394 | 37,106 | ||
| 2021-02-16 | Schaefer Eric Chief Accounting Officer | Grant or award | +5,050 | 92,316 |
Page 14 of 29 · 561 trades